indolent


Also found in: Dictionary, Thesaurus, Legal, Encyclopedia, Wikipedia.
Related to indolent: Indolent lymphoma, Indolent ulcer

indolent

 [in´do-lent]
1. causing little pain.
2. slow growing.

in·do·lent

(in'dō-lent),
Inactive; sluggish; painless or nearly so, said of a morbid process.
[L. in- neg. + doleo, pr. p. dolens (-ent-), to feel pain]

indolent

/in·do·lent/ (in´dah-lint)
1. causing little pain.
2. slow growing.

indolent

(ĭn′də-lənt)
adj.
1.
a. Disinclined to exert oneself; habitually lazy.
b. Conducive to inactivity or laziness; lethargic: humid, indolent weather.
2.
a. Causing little or no pain: an indolent tumor.
b. Slow to heal, grow, or develop; inactive: an indolent ulcer.

in′do·lent·ly adv.

indolent

[in′dələnt]
Etymology: L, in + dolere, to suffer pain
1 pertaining to an organic disorder that is accompanied by little or no pain.
2 slow to heal or grow, e.g., wounds that heal very slowly.

indolent

adjective
Medspeak
Referring to a condition that may linger longer, but often slowly progresses to a more advanced stage—e.g., indolent lymphoma, indolent malignancy, indolent myeloma.

Vox populi
Slow growing.

indolent

Medtalk adjective Referring to a condition which may linger longer, but often slowly progresses to a more advanced stage, as in an indolent CA Vox populi Slow growing

in·do·lent

(in'dō-lĕnt)
Inactive; sluggish; painless or nearly so, said of a morbid process.
[L. in- neg. + doleo, pr. p. dolens (-ent-), to feel pain]

indolent

Of slow progression or taking a long time to heal. Causing little or no pain. Often used of skin ulcers.

indolent

causing little pain; slow growing.

indolent ulcer
see eosinophilic ulcer, refractory ulcer.
References in periodicals archive ?
The indolent clinical course helps exclude rapidly progressing lymphomas, such as primary cutaneous aggressive epidermotropic [CD8.
Despite treatment advances, most indolent NHL patients relapse after, or are refractory to, current therapies, said Robert LaCaze, Executive Vice President and Head of the Oncology Strategic Business Unit at Bayer.
Gazyva continues to be investigated in a large clinical program, which includes the head-to-head Phase III GOYA study compared to MabThera/Rituxan plus chemotherapy in first line diffuse large B-cell lymphoma (DLBCL) and the head-to-head Phase III GALLIUM study compared to MabThera/Rituxan plus chemotherapy in first line indolent non-Hodgkin's lymphoma.
11 In October 2008, it was approved for the treatment of indolent B-cell NHL that has progressed during or within six months of treatment with rituximab or a rituximab-based regimen.
As a prince, he does nothing and is waited on hand and foot, gradually becoming fatter and more indolent, eventually becoming very ill.
9 September 2010 - Danish biotech company Genmab A/S (CPH: GEN) and its R&D partner UK group GlaxoSmithKline (LON: GSK), or GSK, announced today the start of a phase III study with antibody ofatumumab in patients with indolent B-cell non-Hodgkin's lymphoma (B-NHL).
But the richly talented player is still the same indolent, frustrating waste of space that made Gordon Strachan's blood boil at Celtic.
As a reminder, this indolent behavior of Macedonian authorities towards this phenomenon prompted a European threat to countries like Macedonia," says Hajdari.
On the other hand, slow-growing or indolent tumours have blood vessels that look more normal.
Maleski believes Macedonia never proposed any draft resolutions at the UN General Assembly and its foreign policy is getting downright indolent.
Xu conceded that the current risk model has a major limitation: It doesn't distinguish between indolent and aggressive forms of prostate cancer.
Bendamustine is being marketed in the United States as well after the US FDA (Food and Drug Administration) approved for the treatment of chronic lymphocytic leukemia in March 2008 and the treatment of patients with relapsed indolent B-cell non-Hodgkin's lymphoma in October of the same year.